ES8500061A1 - Method for isolating cells obtained by fusing malignant human cells with other human cells producing specific lymphokines or antibodies - Google Patents

Method for isolating cells obtained by fusing malignant human cells with other human cells producing specific lymphokines or antibodies

Info

Publication number
ES8500061A1
ES8500061A1 ES523050A ES523050A ES8500061A1 ES 8500061 A1 ES8500061 A1 ES 8500061A1 ES 523050 A ES523050 A ES 523050A ES 523050 A ES523050 A ES 523050A ES 8500061 A1 ES8500061 A1 ES 8500061A1
Authority
ES
Spain
Prior art keywords
cells
human cells
fusing
antibodies
producing specific
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES523050A
Other languages
Spanish (es)
Other versions
ES523050A0 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of South Carolina
Original Assignee
University of South Carolina
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of South Carolina filed Critical University of South Carolina
Publication of ES8500061A1 publication Critical patent/ES8500061A1/en
Publication of ES523050A0 publication Critical patent/ES523050A0/en
Granted legal-status Critical Current

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

A method is described for separating fused cells which result from the fusion of human cells which are known to produce a specific antibody, or a specific lymphokine, with malignant human companion cells from said companion cells, involving the addition of a specific antiserum which is able to identify antigenic specificities that are unique to the clone and do not react with the non-fused companion cells. After the reaction of the fused cell with the antiserum, the reaction product is separated within 24 hours by means of indirect rosetting.
ES523050A 1982-07-16 1983-06-07 METHOD OF ISOLATING CELLS RESULTING FROM MERGING MALIGNANT HUMAN CELLS WITH OTHER HUMAN CELLS PROTECTING LYMPHOCINES OR SPECIFIC ANTIBODIES. Granted ES523050A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US39883982A 1982-07-16 1982-07-16

Publications (2)

Publication Number Publication Date
ES8500061A1 true ES8500061A1 (en) 1984-10-01
ES523050A0 ES523050A0 (en) 1984-10-01

Family

ID=23576993

Family Applications (1)

Application Number Title Priority Date Filing Date
ES523050A Granted ES523050A0 (en) 1982-07-16 1983-06-07 METHOD OF ISOLATING CELLS RESULTING FROM MERGING MALIGNANT HUMAN CELLS WITH OTHER HUMAN CELLS PROTECTING LYMPHOCINES OR SPECIFIC ANTIBODIES.

Country Status (2)

Country Link
ES (1) ES523050A0 (en)
IT (1) IT1194260B (en)

Also Published As

Publication number Publication date
IT1194260B (en) 1988-09-14
IT8321492A1 (en) 1984-12-07
ES523050A0 (en) 1984-10-01
IT8321492A0 (en) 1983-06-07

Similar Documents

Publication Publication Date Title
Stähli et al. High frequencies of antigen-specific hybridomas: dependence on immunization parameters and prediction by spleen cell analysis
SE8300290D0 (en) PROCESS FOR THE PRODUCTION OF HUMAN MONO-CLONAL ANTIBODIES
SE8001648L (en) PREPARATION OF MONOSPECIFIC ANTIBODY AND USE THEREOF
JPS6447378A (en) Monoclonal antibody to black tumor related antigen, hybrid cell line for producing the same and use thereof
IE811595L (en) Synthetic peptide antigens
EP0066786A3 (en) Method of producing a colon specific antigen p tryptic peptide and anti-colon specific antigen p antibodies
JPS5673029A (en) Production of antibody against hepatitis virus and cell system therefor
ES530853A0 (en) A METHOD FOR SEPARATING A BACTERIAL TOXIN FROM A BIOLOGICAL SAMPLE
DE3167698D1 (en) Method for the determination of antigens with the aid of two or more monoclonal antibodies
DE3175955D1 (en) Process for the deternination of antigens or antibodies
YU306680A (en) Method of obtaining monoclonal antibodies
EP0057107A3 (en) Method of manufacturing monoclonal antibodies and cells capable of manufacturing such antibodies
PT72301A (en) Process for the detection of human cancer cells with antibodies to human cancer nucleolar antigens
DE3278505D1 (en) Hybridoma antibody which inhibits interleukin-2 activity and its use as a reagent for interleukin-2 detection, the production of said antibody, a process for producing hybrid anti-interleukin-2 antibody producing cells, and such cells
ES8500061A1 (en) Method for isolating cells obtained by fusing malignant human cells with other human cells producing specific lymphokines or antibodies
IL68752A (en) Human hybridomas cell lines producing monoclonal antibodies capable of distinguishing neoplastic cells from normal cells,antibodies produced by them and method for determining the presence of a neoplasm by using said antibodies
AU2911289A (en) Carcinoma-associated antigens, and antibodies which recognize these antigens
GB2199833A (en) Preparation of monoclonal antibodies
SE8603711L (en) METHOD OF PRODUCING HUMANA MONOCLONAL ANTIBODIES
JPS6445398A (en) Antithrombin-binding substance monoclonal antibody, hybridoma producing said antibody and method for purifying and measuring thrombin-binding substance utilizing said monoclonal antibody
EP0148644A3 (en) A novel fusion partner and its products
JPS57208458A (en) Labeled antibody for immunochemical measurement
EP0131415A3 (en) Monoclonal antibodies, processes for their preparation and methods for their use
ZA806506B (en) A method for production of monoclonal antibodies
EP0164953A3 (en) Preparation of monoclonal antibodies

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970303